Contribute Try STAT+ Today

In harsh words, the U.S. Department of Justice castigated Purdue Pharma’s proposed bankruptcy plan as being illegal and unconstitutional, raising questions about the fate of the proposal.

Under the proposed settlement, some members of the Sackler family who own the drug maker would contribute more than $4.3 billion to compensate people and local governments that were harmed by OxyContin, the painkiller that helped trigger the opioid crisis. In exchange, the family and a lengthy list of associates, who did not file for bankruptcy protection, would be immune from future lawsuits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment